Optos, PLC
Clinical trials sponsored by Optos, PLC, explained in plain language.
Ophthalmic imaging device manufacturer (acquired by Nikon, delisted).
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a modified camera capture better images of diseased retinas? Results expected Oct 2026 (estimated)
-
Can a modified camera capture better images of diseased retinas?
Knowledge-focused Recruiting nowThis study tests a modified P200TE imaging device to see how well it captures images of the retina in people with posterior segment eye diseases, such as age-related macular degeneration, glaucoma, and diabetic retinopathy. Researchers will collect images from 50 adults with thes…
Sponsor: Optos, PLC • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New eye scanner tested on 180 volunteers – no treatment involved
Knowledge-focused Recruiting nowThis study gathers eye scan images from 180 people with healthy eyes or eye diseases like glaucoma and retinal disease. The goal is to collect data using a new optical coherence tomography (OCT) device called A10900. No treatment or medication is given. The information will help …
Sponsor: Optos, PLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC